Allyte 1% Gel 20gm

INTRODUCTION

ALLYTE 1% contains Clindamycin which belongs to the group of medicines called Topical antibiotics. It is used for the topical treatment of acne vulgaris. Acne vulgaris is a common skin condition that occurs in teens when hair follicles of the skin plug with oil and dead skin cells. Symptoms includes inflammation, large, reddish pus-filled pimples and formation of comedones.

Clindamycin deeply penetrates into the skin and kills the pimple-causing bacteria by inhibiting the bacterial protein synthesis. It is for external use only. Apply a thin layer of this medicine on the affected area as required. Topical application of clindamycin may also result in systemic absorption of the antibiotic from the skin surface and can cause diarrhea, bloody diarrhea or colitis (including pseudomembranous colitis) in patients. In such cases, contact your doctor immediately.

The most common side effects of this medicine are application site reactions such as itching, redness, peeling of skin or skin rash.  Do not touch, rub or scratch the affected area. Regularly use moisturizers to soothe and hydrate the affected area. If it does not get better, contact your doctor. Before applying this medicine, inform your doctor if you have or ever had any GI disorders. ALLYTE 1% is strictly not recommended for use in children under 12 years of age. Consult your doctor before application.

• Treats acne vulgaris

Topically applied clindamycin penetrates deep into the skin and kills the acne-producing bacteria by inhibiting the bacterial protein synthesis. It acts by reversibly binding to the 50S ribosomal subunits of the bacteria, which prevents peptide bond formation thus inhibiting bacterial protein synthesis. Inhibition of protein synthesis stops the growth of acne-producing bacteria leading to prevention of acne outbreaks.

Apply this medicine as directed by your physician. It is for external use only. Before application, wash your face with mild soap and warm water. Apply a thin film of the medicine to the affected skin surface once or twice daily. Avoid contact of this medicine with eyes, ears, nose or mouth. If this happens, rinse it thoroughly with water. Continue to apply this medicine, as long as your doctor tells you to do so, to obtain better results.

Skin rash:

Avoid hot showers because hot water can irritate the skin. Do not rub or scratch the affected area. Use sunscreen and protective clothing when outdoors. Regularly use moisturizers to soothe and hydrate the affected area. If it does not get better, speak to your doctor.

WARNING & PRECAUTIONS

Tell your healthcare provider if you are using any other topical preparations.

SYNOPSIS

Store below 20-25°C and keep out of reach of children.

Can I apply ALLYTE 1% on my face?

Yes. This medicine is intended for application on the face to cure acne outbreaks.

How to use ALLYTE 1%?

Wash your face with mild soap and warm water. Pat it dry. Apply a thin film of the medicine to the affected skin surface once or twice daily. If your skin feels too dry, you can apply this medicine once daily. Continue to apply this medicine, as long as your doctor tells you to do so, to obtain better results.

Can I use ALLYTE 1% when I’m pregnant?

Yes. This medicine is considered safe for use in pregnant women. However, consult your doctor before application.

Can I apply moisturizer after applying ALLYTE 1%?

Yes. If your skin feels too dry after using this medicine, you can apply a moisturizer to soothe and hydrate the affected area.

1. KD. Tripathi. Macrolide, Lincosamide, Glycopeptide and Other Antibacterial Antibiotics; Urinary Antiseptics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 756-757.

2. KD. Tripathi. Drugs Acting on Skin and Mucous Membranes. Essentials of medical pharmacology. Seventh edition. 2013. Page – 894.

3. Conan MacDougall and Henry F. Chambers. Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1534-1535.

4. Gerald G. Briggs and Roger K. Freeman. C. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 856-857.

5. Stiefel. Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects with Acne. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on November 2016] [Accessed 9th December 2020]

6. Akorn, Inc. Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on October 2020] [Accessed 9th December 2020]

7. Bhavik Bhavsar, Bimal Choksi, Jayesh Sanmukhani, Alka Dogra, Rizwan Haq, Sudhanshu Mehta, Santanu Mukherjee, V Subramanian, Shafiq Sheikh and Ravindra Mittal. Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial. NCBI; PMC US National Library of Medicine, National Institute of Health. January-August 2014. [Accessed 9th December 2020]

8. Ortho Dermatologics. U.S. Food & Drug Administration. [Revised on September 2015] [Accessed 9th December 2020]